Assignee profile:

VARIATION BIOTECHNOLOGIES INC.

City:

Ottawa

Country:

Canada

Published Applications:

20

Last publication date:

2023-08-31

Patent Grants:

15

Last grant date:

2025-09-23

Top Inventors for applications by VARIATION BIOTECHNOLOGIES INC.

These are the the leading inventors for applications assigned to VARIATION BIOTECHNOLOGIES INC.:

Recent patent applications by VARIATION BIOTECHNOLOGIES INC.

VARIATION BIOTECHNOLOGIES INC. based in Ottawa, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-31 ✅ Patent 12,421,283 granted on 2025-09-23
US20230272013A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOMEGALOVIRUS

#2 | 2023-03-16 ✅ Patent 12,128,100 granted on 2024-10-29
US20230079703A1
Human necessities

Immunogenic compositions for treatment of Hepatitis B

#3 | 2023-01-26
US20230022956A1
Human necessities

IMMUNOTHERAPEUTIC COMPOSITIONS

#4 | 2021-11-18 ✅ Patent 11,253,587 granted on 2022-02-22
US20210353741A1
Human necessities

Vaccine compositions for the treatment of coronavirus

#5 | 2021-03-11
US20210069321A1
Human necessities

IMMUNOTHERAPEUTIC COMPOSITIONS

#6 | 2018-09-13 ✅ Patent 11,167,033 granted on 2021-11-09
US20180256723A1
Human necessities

Compositions and methods for treating viral infections

#7 | 2018-08-16 ✅ Patent 11,167,032 granted on 2021-11-09
US20180228899A1
Human necessities

Methods and compositions for therapeutic agents

#8 | 2017-12-07 ✅ Patent 11,248,026 granted on 2022-02-15
US20170349634A1
Chemistry; metallurgy

Compositions and methods for treatment of cytomegalovirus

#9 | 2017-12-05 ✅ Patent 9,833,505 granted on 2017-12-05
US15642950
Human necessities

Vaccine compositions for treatment of Zika virus

#10 | 2017-04-27 ✅ Patent 10,105,440 granted on 2018-10-23
US20170112924A1
Human necessities

Synthetic derivatives of MPL and uses thereof

#11 | 2015-02-12 ✅ Patent 10,006,096 granted on 2018-06-26
US20150044668A1
Chemistry; metallurgy

Methods for detection of anti-cytomegalovirus neutralizing antibodies

#12 | 2014-12-18 ✅ Patent 9,603,920 granted on 2017-03-28
US20140370041A1
Human necessities

Compositions and methods for treating influenza

#13 | 2014-10-16 ✅ Patent 9,777,043 granted on 2017-10-03
US20140308308A1
Chemistry; metallurgy

Compositions and methods for treatment of cytomegalovirus

#14 | 2013-11-07 ✅ Patent 10,736,844 granted on 2020-08-11
US20130295165A1
Human necessities

Compositions and methods for treating viral infections

#15 | 2012-07-12 ✅ Patent 9,907,746 granted on 2018-03-06
US20120177683A1
Human necessities

Methods for preparing vesicles and formulations produced therefrom

#16 | 2012-06-21 ✅ Patent 9,849,173 granted on 2017-12-26
US20120156240A1
Human necessities

Methods for preparing vesicles and formulations produced therefrom

#17 | 2011-01-27
US20110020381A1
Chemistry; metallurgy

INFLUENZA VACCINE FORMULATION

#18 | 2009-04-23
US20090104216A1
Human necessities

Peptide-Based Influenza Vaccine Formulation

#19 | 2006-10-26
US20060240030A1
Chemistry; metallurgy

ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF

#20 | 2006-10-10 ✅ Patent 7,118,874 granted on 2006-10-10
US10072084
-

Immunogenic formulation and process for preparation thereof

Also check out Variation Biotechnologies Inc.'s (Ottawa, Canada) applicant profile with 11 patent applications submitted.

AssigneeID:

196846 ⎘